Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000898432-25-000342·Amneal Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
Amneal Pharmaceuticals Inc
Class A Common Stock, par value $0.01 · CUSIP: 03168L105
Event date: 2025-03-31
- Filing-level shares
- 20,558,759
- Percent of class
- 6.56%
- Akram Mahesh
Shares: 20,558,759 · Class: 6.56%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000898432-25-000342
- Form type
- SCHEDULE 13G/A
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- May 14, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership